|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$95,744.61 |
3.09% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$88,958.21 |
2.87% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$86,997.17 |
2.81% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,900.29 |
2.68% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$82,435.93 |
2.66% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$80,966.73 |
2.61% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,440.14 |
2.60% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$79,975.33 |
2.58% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$78,842.97 |
2.55% |
| Waters Corporation |
WAT |
941848103 |
184 |
$77,029.76 |
2.49% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$76,764.08 |
2.48% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$76,514.74 |
2.47% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$74,424.96 |
2.40% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,799.40 |
2.38% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$71,845.77 |
2.32% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,466.70 |
2.24% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,399.76 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$67,584.96 |
2.18% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$66,060.33 |
2.13% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$65,620.25 |
2.12% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$64,591.60 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,079.41 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,695.64 |
2.06% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$63,744.00 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$62,597.60 |
2.02% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,041.05 |
2.00% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$61,261.74 |
1.98% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$60,187.68 |
1.94% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$58,888.50 |
1.90% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$58,616.64 |
1.89% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,675.20 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,444.75 |
1.82% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,623.50 |
1.80% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,581.83 |
1.67% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$51,153.00 |
1.65% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,236.43 |
1.65% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,500.82 |
1.63% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$49,697.70 |
1.60% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$49,548.24 |
1.60% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,069.52 |
1.58% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$49,047.12 |
1.58% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,097.99 |
1.52% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,377.84 |
1.50% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$45,217.08 |
1.46% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,547.12 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,146.55 |
1.36% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$42,180.00 |
1.36% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,934.05 |
1.35% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,315.32 |
1.33% |
| US Dollar |
$USD |
|
12,931 |
$12,931.05 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|